Singletary Oncology Center Hosts New Smoking Cessation Program

Posted on

Singletary Oncology Center Hosts New Smoking Cessation Program

Wednesday, January 23, 2013

According the American Cancer Society, tobacco use is responsible for one in five deaths in the United States every year. In addition, smoking is directly responsible for approximately 90 percent of lung cancer deaths and approximately 80-90 percent of COPD (emphysema and chronic bronchitis) deaths.

But because cigarette smoking and tobacco use are acquired behaviors—activities that people choose to do—using tobacco is also the most preventable cause of death in our society.

For many though, quitting is easier said than done.

Most tobacco users recognize the health risks, but The American Lung Association estimates that six out of ten smokers require multiple attempts to quit smoking.

Archbold Memorial Hospital’s Lewis Hall Singletary Oncology Center will host a seven week smoking cessation program, focusing exclusively on how to quit and using proven techniques and methods designed to help smokers gain control over their behavior.

Singletary Oncology Center social workers Terry Trent and Tina Williams will serve as course instructors.

“We are delighted to offer this unique program to our community,” said Williams. “Since no single cessation technique has proven effective for all smokers, our new program was designed to offer a comprehensive variety of evidence-based cessation techniques.”

Trent added, “What makes our program unique is the support system. Participants will benefit from the support of their peers, who are going through the same stages at the same time.”

The first class will be held on January 30, from 5—6pm in the community room at the Singletary Oncology Center. The seven-week course is free to the community, as part of Archbold’s Clinical Outreach Program, supporting Archbold’s core value of community benefit.

For more information on the smoking cessation program, call Tina Williams, (229) 584-5462 or click here to register.